Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(24):2067-2068; doi:10.1093/jnci/91.24.2067
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ellis, M. J.
Right arrow Articles by Hayes, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellis, M. J.
Right arrow Articles by Hayes, D. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 24, 2067-2068, December 15, 1999
© 1999 Oxford University Press

EDITORIALS

Refining Breast Cancer Risk Assessment With Molecular Markers: the Next Step?

Matthew J. Ellis, Daniel F. Hayes

Affiliation of authors: Breast Cancer Program, Lombardi Cancer Center, Georgetown University Medical Center, Washington DC.

Correspondence to: Daniel F. Hayes, M.D., Breast Cancer Program, Lombardi Cancer Center, Georgetown University Medical Center, 3970 Reservoir Rd., N.W., Washington, DC 20007 (e-mail: ellism@gunet.georgetown.edu).

It is now reasonably well established that tamoxifen reduces the incidence of new breast cancers (1). Prevention strategies are much more efficiently applied to populations most likely to develop the disease. Therefore, considerable effort has been focused on developing risk profile indices for breast cancer development (2,3). Currently available models have depended principally on clinical and morphologic criteria.

Breast epithelial hyperplasia lacking atypia (EHLA) is at the most benign end of a spectrum of breast lesions associated with a risk of developing invasive carcinoma. Although . . . [Full Text of this Article]

NOTES

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
R. T. Chlebowski
Reducing the Risk of Breast Cancer
N. Engl. J. Med., July 20, 2000; 343(3): 191 - 198.
[Full Text] [PDF]